MRP Capital Investments LLC Has $1.73 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)

MRP Capital Investments LLC decreased its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 46.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 17,120 shares of the company's stock after selling 14,674 shares during the period. Cardinal Health makes up 1.9% of MRP Capital Investments LLC's portfolio, making the stock its 12th largest position. MRP Capital Investments LLC's holdings in Cardinal Health were worth $1,726,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Friedenthal Financial acquired a new position in Cardinal Health in the 4th quarter worth $693,000. G&S Capital LLC boosted its stake in Cardinal Health by 2.0% in the 4th quarter. G&S Capital LLC now owns 9,596 shares of the company's stock worth $967,000 after purchasing an additional 189 shares during the period. Cerity Partners LLC boosted its stake in Cardinal Health by 35.7% in the 4th quarter. Cerity Partners LLC now owns 18,515 shares of the company's stock worth $1,867,000 after purchasing an additional 4,875 shares during the period. Aaron Wealth Advisors LLC boosted its stake in Cardinal Health by 1.2% in the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company's stock worth $844,000 after purchasing an additional 97 shares during the period. Finally, Sequoia Financial Advisors LLC lifted its position in Cardinal Health by 41.2% during the 4th quarter. Sequoia Financial Advisors LLC now owns 5,330 shares of the company's stock worth $537,000 after buying an additional 1,556 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Wall Street Analyst Weigh In


Several equities research analysts have commented on CAH shares. Argus raised shares of Cardinal Health from a "hold" rating to a "buy" rating in a research report on Friday, February 9th. Leerink Partnrs reissued an "outperform" rating on shares of Cardinal Health in a research report on Monday, February 26th. SVB Leerink started coverage on shares of Cardinal Health in a research report on Monday, February 26th. They set an "outperform" rating and a $125.00 price target on the stock. UBS Group boosted their price target on shares of Cardinal Health from $122.00 to $125.00 and gave the stock a "buy" rating in a research report on Monday, February 5th. Finally, TheStreet cut shares of Cardinal Health from a "b-" rating to a "c+" rating in a research report on Wednesday, December 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $103.07.

Get Our Latest Analysis on Cardinal Health

Cardinal Health Price Performance

Cardinal Health stock traded down $1.32 during trading hours on Friday, hitting $105.10. The company had a trading volume of 1,514,182 shares, compared to its average volume of 2,277,511. The firm has a market cap of $25.56 billion, a PE ratio of 41.38, a PEG ratio of 1.04 and a beta of 0.68. Cardinal Health, Inc. has a one year low of $77.56 and a one year high of $116.04. The firm has a 50-day moving average of $109.32 and a 200 day moving average of $103.51.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.26. The firm had revenue of $57.45 billion for the quarter, compared to analysts' expectations of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The business's revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.32 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 7.28 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Shareholders of record on Monday, April 1st will be given a dividend of $0.5006 per share. The ex-dividend date is Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.91%. Cardinal Health's payout ratio is presently 78.74%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Cardinal Health right now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: